A Newsletter “Readable and Useful on the Train
In 2022, the Japanese Journal of Pharmacokinetics (JJDPK) celebrated its 20th anniversary. （The newsletter has been published since the first term (Chairperson: Dr. Tamai), the second term (Chairperson: Dr. Yamazaki), and the third term (Chairperson: Dr. Yuasa), and has become deeply familiar to readers. In the 4th period (Chairperson: Matsunaga), the DMPK was transferred to Elsevier’s online journal, and since 2015, it has been renewed as an electronic version that “can be read on the train and is informative” and has passed through the 5th period (Chairperson: Maekawa). Although the frequency of train travel is decreasing with the spread of telework, we will continue to aim to provide information that is both “easy” to read on a smartphone or tablet and “useful” and informative, so we hope you will continue to read our newsletter.
While we use the word “read” because it is a news “letter,” the means of information dissemination are diversifying with the evolution of the Web, and it is no longer necessary to stick only to textual information. In the 6th Committee, based on President Yamashita’s policy that “we would like to work on multimedia information provision” ( Greeting from the 17th President of the Japanese Society of Pharmacokinetics, Newsletter 36(6)), we plan to actively work on information transmission in video format, which can be “easily” viewed with smartphones and tablets. Each has its own merits and demerits, and we would be grateful for your frank opinions.
The sixth committee consists of a diverse group of members from pharmaceutical companies, academia, and hospitals ( list of editorial board members), totaling 14 members. Taking advantage of the diversity and network of the Editorial Committee, we plan to actively provide “useful” information to our members, such as a series of articles to help you understand the pharmacokinetic characteristics of each of the various modalities.
The newsletter is made possible by the cooperation of our members, including the writing of manuscripts. Thank you for your continued support.
Newsletter Editor-in-Chief
Masatoshi Tomi
Faculty of Pharmaceutical Sciences, Keio University